Sponsor

Sciensano

Belgium Juliette Wytsmanstraat 14, 1050, Belgium

About the sponsor

Research activity centers on SARS-CoV-2 immunity, with attention to binding antibodies and neutralizing antibodies against circulating variants of concern.

Viral immunity surveillance
Variant-specific antibody responses
Population-level immune monitoring

The clinical focus includes repeated assessment of immune status in relation to the epidemiologically predominant COVID-19 variant.

About Specializations

Sciensano runs clinical trials in conditions such as COVID-19, among others.

COVID-19

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Quick filters

1 clinical trial

COVID-19

Not yet recruiting

Registered drugNo placebo

Study on COVID-19 Immunity in Immunocompromised Adults Using Raxtozinameran and Bretovameran in Belgium

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years · Healthy volunteers
Substances:Raxtozinameran
Sponsor:Sciensano

Contact Research Centre

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →